BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22984686)

  • 1. Effect of troglitazone on radiation sensitivity in cervix cancer cells.
    An Z; Liu X; Song H; Choi C; Kim WD; Yu JR; Park WY
    Radiat Oncol J; 2012 Jun; 30(2):78-87. PubMed ID: 22984686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells.
    Liu X; Jang SS; An Z; Song H; Kim WD; Yu JR; Park WY
    Radiat Oncol J; 2012 Jun; 30(2):88-95. PubMed ID: 22984687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines.
    Bae MA; Rhee H; Song BJ
    Toxicol Lett; 2003 Mar; 139(1):67-75. PubMed ID: 12595159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor γ co-activator-1α protein.
    Liao X; Wang Y; Wong CW
    Br J Pharmacol; 2010 Oct; 161(4):771-81. PubMed ID: 20860658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
    Yin F; Wakino S; Liu Z; Kim S; Hsueh WA; Collins AR; Van Herle AJ; Law RE
    Biochem Biophys Res Commun; 2001 Sep; 286(5):916-22. PubMed ID: 11527386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone, a Selective Ligand for PPARγ, Induces Cell-cycle Arrest in Human Oral SCC Cells.
    Saito M; Fujita Y; Kuribayashi N; Uchida D; Komiyama Y; Fukumoto C; Hasegawa T; Kawamata H
    Anticancer Res; 2020 Mar; 40(3):1247-1254. PubMed ID: 32132021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells.
    Bae MA; Song BJ
    Mol Pharmacol; 2003 Feb; 63(2):401-8. PubMed ID: 12527812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
    Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.
    Rachek LI; Yuzefovych LV; Ledoux SP; Julie NL; Wilson GL
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):348-54. PubMed ID: 19632256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
    Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M
    Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.
    Gouni-Berthold I; Berthold HK; Weber AA; Ko Y; Seul C; Vetter H; Sachinidis A
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):215-21. PubMed ID: 11218074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
    Han EJ; Im CN; Park SH; Moon EY; Hong SH
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines.
    Turturro F; Friday E; Fowler R; Surie D; Welbourne T
    Clin Cancer Res; 2004 Oct; 10(20):7022-30. PubMed ID: 15501982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
    Mu YM; Yanase T; Nishi Y; Waseda N; Oda T; Tanaka A; Takayanagi R; Nawata H
    Biochem Biophys Res Commun; 2000 May; 271(3):710-3. PubMed ID: 10814527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
    Narayanan PK; Hart T; Elcock F; Zhang C; Hahn L; McFarland D; Schwartz L; Morgan DG; Bugelski P
    Cytometry A; 2003 Mar; 52(1):28-35. PubMed ID: 12596249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.
    Wakino S; Kintscher U; Liu Z; Kim S; Yin F; Ohba M; Kuroki T; Schönthal AH; Hsueh WA; Law RE
    J Biol Chem; 2001 Dec; 276(50):47650-7. PubMed ID: 11598137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro.
    Ye J; Yin L; Xie P; Wu J; Huang J; Zhou G; Xu H; Lu E; He X
    Onco Targets Ther; 2015; 8():1211-8. PubMed ID: 26060406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells.
    Yin F; Bruemmer D; Blaschke F; Hsueh WA; Law RE; Herle AJ
    Oncogene; 2004 Jun; 23(26):4614-23. PubMed ID: 15064713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
    Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
    Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism.
    Artwohl M; Fürnsinn C; Waldhäusl W; Hölzenbein T; Rainer G; Freudenthaler A; Roden M; Baumgartner-Parzer SM
    Diabetologia; 2005 Mar; 48(3):586-94. PubMed ID: 15729575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.